960 x 350_41

小分子和大分子 LC-MS

准确测量和定量相关基质中可提示临床药物开发的许多方面的生物标志物。生物标志物分析可以为患者匹配合适的治疗,并证明候选药物的安全性和疗效,从而揭示其临床和商业成功的可能性。Q2 Solutions 提供广泛的定制和整合液相色谱质谱服务,以支持生物标志物测定和定量,包括液质联用 (LC/MS) 生物分析、LC/MS/MS 分析、混合 LC-MS 测定、小分子 LC/MS 和大分子生物分析。

我们的团队拥有开发和验证内源性分析物(例如蛋白质、肽、脂质)以及小分子/大分子及其代谢物多重 LC/MS 测定的丰富经验。Q2 Solutions 的 LC/MS/MS 生物分析服务符合药物非临床研究质量管理规范 (GLP) 和药物临床试验质量管理规范 (GCP) 要求,支持美国食品药品监督管理局(FDA)、经济合作与发展组织(OECD)、日本厚生劳动省(MHLW)、以及国际人用药品注册技术协调会(ICH)标准。

相关思想领袖见解


Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...

Bioanalytical Testing & LC/MS/MS Analysis

Q2 Solutions is a leading drug discovery and development laboratory services organization with over 30 years of experience specializing in GLP-compliant bioanalytical testing. Our updated and...

A Process of Method Development for Tissue Homogenization and Analysis to Eliminate Binding and Matrix Effects Using Surrogate Matrices

The analysis and distribution of pharmaceuticals in tissue is increasingly important in understanding the full action of drugs in vivo. Across molecular types from very small molecules to larger...